Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |